{
    "nct_id": "NCT04311073",
    "official_title": "Randomized Control Trial Investigating for Prophylactic Tranexamic Acid Use at Time of Minimally Invasive Myomectomies",
    "inclusion_criteria": "* Undergoing laparoscopic myomectomy\n* At least one fibroid greater than or equal to 6 cm\n* Any intramural or broad ligament fibroid greater than or equal to 4 cm\n* At least 3 total fibroids based on preoperative imaging\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years\nMust have maximum age of 45 Years",
    "exclusion_criteria": "* Severe existing medical complications involving the heart, liver, or kidney\n* Moderate to severe renal impairment (serum creatinine > 1.4)\n* Blood clotting abnormalities\n* Known Allergies to tranexamic acid\n* Known Contraindications to Minimally invasive myomectomies\n* If you are pregnant\n* History of a prior blood clot in the lung arm or leg, known as pulmonary embolism or deep vein thrombosis\n* Any active blood clots, clotting disease, pulmonary embolism, cerebral thrombosis, estrogen use, renal impairment, elevated creatinine level\n* History of a stroke or mini-strokes\n* Concurrent oral contraceptive use\n* Contraindications to receiving Tranexamic acid\n* In patients with acquired defective color vision, since this prohibits measuring one endpoint that should be followed as a measure of toxicity\n* In patients with subarachnoid hemorrhage. Anecdotal experience indicates that cerebral edema and cerebral infarction may be caused by tranexamic acid in such patients.\n* In patients with active intravascular clotting.\n* In patients with hypersensitivity to tranexamic acid or any of the ingredients",
    "miscellaneous_criteria": ""
}